Skip to content

The effect of soybean intake on disease severity, quality of life and hematologic factors of patients with ulcerative colitis

The effect of soybean intake on disease severity, quality of life and hematologic factors of patients with ulcerative colitis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191113045432N1
Enrollment
40
Registered
2020-01-24
Start date
2020-11-21
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colitis ulcerative. Ulcerative colitis, unspecified

Interventions

Intervention 1: Intervention group: daily intake of 30 g soybean produced by sobhan company along with routine treatment for colitis ulcerative patients. Intervention 2: Control group: routine treatme

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with colitits ulcerative with moderate severity

Exclusion criteria

Exclusion criteria: Alteration in type of drugs used for treatment of IBD within last 3 months Having other gut diseases such as related cancers and infections Pregnancy and lactation Admitting in hospital during last 3 months History of gut infections during last 3 months Using multivitamin/mineral supplements during last month

Design outcomes

Primary

MeasureTime frame
Disease severity for colitis ulcerative. Timepoint: At the baseline and end of intervention. Method of measurement: Mayo-score questionnaire for colitis ulcerative.;Quality of life. Timepoint: At the baseline and end of intervention. Method of measurement: Questionnaire.;CBC. Timepoint: At the baseline and end of intervention. Method of measurement: Cell counter device.;ESR. Timepoint: At the baseline and end of intervention. Method of measurement: Wintergreen.;Disability caused by the disease. Timepoint: At the baseline and end of intervention. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSina Naghshi

Tehran University of Medical Sciences

naghshi_sina@yahoo.com+98 21 8895 5742

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026